서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Subject

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 28 of 28

Issue DateTitle / Author(s) / CitationFileAltmetrics
2006
Treatment result of childhood rhabdomyosarcoma : treatment outcome and analysis of prognostic factors
link
2009-04
Complete Remission Status before Autologous Stem Cell Transplantation Is an Important Prognostic Factor in Patients with Multiple Myeloma Undergoing Upfront Single Autologous Transplantation
DOI
2010-05
Systematic Lymphadenectomy for Survival in Epithelial Ovarian Cancer A Meta-Analysis
DOI
2014-03
Clinical Significance of Downstaging in Patients With Limited-Disease Small-Cell Lung Cancer
DOI
2014-08
The presence of extrathoracic metastasis is more prognostic of survival than Masaoka stage (IVa/IVb) in metastatic thymic epithelial tumor: A retrospective cohort study
DOI
2016-01
Correlation of KIT and PDGFRA mutational status with clinical benefit in patients with gastrointestinal stromal tumor treated with sunitinib in a worldwide treatment-use trial
view fileDOI
2016-01
The role of primary tumor resection in colorectal cancer patients with asymptomatic, synchronous unresectable metastasis: Study protocol for a randomized controlled trial
view file
2017-01
Signature of cytokines and angiogenic factors (CAFs) defines a clinically distinct subgroup of gastric cancer
DOI
2017-08
Study of the effects of miR-200 overexpression and LOXL4 downregulation on triple-negative breast cancer progression
view file
2018-05
Subgroup analysis of patients with HER2-negative metastatic breast cancer in the second-line setting from a phase 3, open-label, randomized study of eribulin mesilate versus capecitabine

Pivot, Xavier; Im, Seock Ah; Guo, Matthew; Marme, Frederik

Breast Cancer, Vol.25 No.3, pp.370-374

DOI
2018-11
Buparlisib plus fulvestrant versus placebo plus fulvestrant for postmenopausal, hormone receptor-positive, human epidermal growth factor receptor 2-negative, advanced breast cancer: Overall survival results from BELLE-2
DOI
2019-01
Epidermal growth factor receptor gene amplification predicts worse outcome in patients with surgically resected nonadenocarcinoma lung cancer

Chang, Hyun; Yang, Yaewon; Lee, Jong-Seok; Jheon, Sang-Hoon; Kim, Yu Jung; Chung, Jin-Haeng

Clinical Lung Cancer, Vol.20 No.1, pp.7-12.e1

DOI
2019-05
Adjuvant cytokine-induced killer cell immunotherapy for hepatocellular carcinoma: a propensity score-matched analysis of real-world data
view fileDOI
2019-11
Poor prognostic factors in human papillomavirus-positive head and neck cancer: who might not be candidates for de-escalation treatment?
view fileDOI
2020-01
Pooled overall survival and safety data from the pivotal phase II studies (NP28673 and NP28761) of alectinib in ALK-positive non-small-cell lung cancer
DOI
2020-02
Survival outcomes of breast cancer patients with brain metastases: A multicenter retrospective study in Korea (KROG 16-12)
DOI
2021-08
Prognostic significance of the postoperative prognostic nutritional index in patients with glioblastoma: a retrospective study
view fileDOI
2021-12
Novel prognostic classification predicts overall survival of patients receiving salvage whole-brain radiotherapy for recurrent brain metastasis from breast cancer: A recursive partitioning analysis (KROG 16-12)
DOI
2021-12
Germline breast cancer susceptibility genes, tumor characteristics, and survival
view fileDOI
2022-10
The Pattern of Care for Brain Metastasis from Breast Cancer Over the Past 10 Years in Korea: A Multicenter Retrospective Study (KROG 16-12)
DOI
2023-05
Survival advantage of locoregional and systemic therapy in oligometastatic breast cancer: an international retrospective cohort study (OLIGO-BC1)
DOI
2023-05
OlympiAD extended follow-up for overall survival and safety: Olaparib versus chemotherapy treatment of physician?s choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer
DOI
2023-07
Comparison of initial and sequential salvage brain-directed treatment in patients with 1-4 vs. 5-10 brain metastases from breast cancer (KROG 16-12)
DOI
2023-08
Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2− advanced breast cancer receiving first-line ribociclib plus fulvestrant
DOI
2023-08
Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2− advanced breast cancer receiving first-line ribociclib plus fulvestrant
view fileDOI
2023-12
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY

Balmana, Judith; Fasching, Peter A.; Couch, Fergus J.; Delaloge, Suzette; Labidi-Galy, Intidhar; O'Shaughnessy, Joyce; Park, Yeon Hee; Eisen, Andrea F.; You, Benoit; Bourgeois, Hughes; Goncalves, Anthony; Kemp, Zoe; Swampillai, Angela; Jankowski, Tomasz; Sohn, Joo Hyuk; Poddubskaya, Elena; Mukhametshina, Guzel; Aksoy, Sercan; Timcheva, Constanta V.; Park-Simon, Tjoung-Won; Anton-Torres, Antonio; John, Ellie; Baria, Katherine; Gibson, Isabel; Gelmon, Karen A.; Koynova, Tatyana; Popov, Vasil; Timcheva, Constanta; Tomova, Antoaneta; Eisen, Andrea; Gelmon, Karen; Lemieux, Julie; Augereau, Paule; Bazan, Fernando; Becuwe, Celia; Bourgeois, Hugues; Chakiba, Camille; Chehimi, Mohamad; Cheneau, Caroline; Dalenc, Florence; de Guillebon, Eleonore; de la Motte Rouge, Thibault; Frenel, Jean-Sebastien; Goncalves, Anthony; Grenier, Julien; Hardy-Bessard, Anne Claire; Lamy, Regine; Levy, Christelle; Lortholary, Alain; Mailliez, Audrey; Medioni, Jacques; Patsouris, Anne; Spaeth, Dominique; Teixeira, Luis; Tennevet, Isabelle; Venat-Bouvet, Laurence; Villanueva, Cristian; You, Benoit; Ettl, Johannes; Fasching, Peter; Gerber, Bernd; Hanusch, Claus Alexander; Hoffmann, Oliver; Park-Simon, Tjoung-Won; Malter, Wolfram; Reinisch, Mattea; Tio, Joke; Wimberger, Pauline; Boer, Katalin; Dank, Magdolna; Ballestrero, Alberto; Bianchini, Giampaolo; Biganzoli, Laura; Bordonaro, Roberto; Cognetti, Francesco; Cortesi, Enrico; De Laurentiis, Michelino; De Placido, Sabino; Gianni, Luca; Guarneri, Valentina; Marchetti, Paulo; Montemurro, Filippo; Mosconi, Anna Maria; Naso, Giuseppe; Puglisi, Fabio; Santoro, Armando; Zamagni, Claudio; Iwata, Hiroji; Kim, Seung-Jin; Nakamura, Seigo; Chae, Yee Soo; Cho, Eun Kyung; Kim, Jee Hyun; Im, Seock-Ah; Lee, Keun Seok; Park, Yeon Hee; Sohn, Joo Hyuk; Byrski, Tomasz; Huzarski, Tomasz; Jankowski, Tomasz; Kukielka-Budny, Bozena; Lacko, Aleksandra; Nowecki, Zbigniew; Senkus-Konefka, Elzbieta; Szoszkiewicz, Renata; Tarnawski, Rafal; Andabekov, Timur; Dvorkin, Mikhail; Dvornichenko, Viktoria; Moiseenko, Fedor; Mukhametshina, Guzel; Poddubskaya, Elena; Popova, Ekaterina; Tarasova, Anna; Sakaeva, Dina; Shomova, Marina; Vats, Anna; Adamo, Barbara; Conejero, Raquel Andres; Torres, Antonio Anton; Gelpi, Judith Balmana; de Ibarguen, Blanca Cantos Sanchez; Jurado, Josefina Cruz; Fernandez, Nieves Diaz; Gonzalez, Alejandro Falcon; Garcia, Juan; Santiago, Santiago Gonzalez; Carrasco, Fernando Henao; Lorenzo, Isabel Lorenzo; Anton, Fernando Moreno; Garcia, Beatriz Rojas; Beltran, Salomon Menjon; Santisteban, Marta; Stradella, Agostina; Hou, Ming-Feng; Huang, Chiun-Sheng; Lin, Yung-Chang; Tseng, Ling-Ming; Wang, Hwei-Chung; Aksoy, Sercan; Arslan, Cagatay; Artac, Mehmet; Aydiner, Adnan; Disel, Umut; Ozkan, Metin; Ozyilkan, Ozgur; Sezer, Emel Yaman; Yetisyigit, Tarkan; Armstrong, Anne; Barrett, Sophie; Borley, Annabel; Kemp, Zoe; Michie, Caroline; Mukesh, Mukesh; Perren, Timothy; Swampillai, Angela; Chaudhry, Madhu; Young, Tammy

BREAST CANCER RESEARCH AND TREATMENT

DOI
2024-01
Increased risk of contralateral breast cancer for BRCA1/2 wild-type, high-risk Korean breast cancer patients: a retrospective cohort study
view fileDOI
2024-04
Lazertinib as a frontline treatment in patients with EGFR-mutated advanced non-small cell lung cancer: Long-term follow-up results from LASER201
DOI
1